nafamostat has been researched along with fibrinogen in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shibata, A; Takahashi, H | 1 |
| Furukawa, Y; Kato, H; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T | 1 |
| Ohta, K; Orita, K; Tanaka, N | 1 |
| Hryszko, T; Ihara, H; Inaba, K; Mogami, H; Suzuki, Y; Urano, T | 1 |
| Matsumoto, T; Wada, H; Yamashita, Y | 1 |
| Harada, S; Ikeda, M; Jubishi, D; Kanno, Y; Kurano, M; Moriya, K; Okamoto, K; Okugawa, S; Osawa, I; Otani, A; Shinohara, T; Wakimoto, Y; Yamashita, M; Yatomi, Y | 1 |
1 review(s) available for nafamostat and fibrinogen
| Article | Year |
|---|---|
[Recent therapeutic strategy for disseminated intravascular coagulation].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coagulation; Fibrinogen; Gabexate; Guanidines; Heparin; Humans; Molecular Targeted Therapy; Plasma; Platelet Transfusion; Practice Guidelines as Topic; Serine Proteinase Inhibitors; Thrombomodulin | 2014 |
5 other study(ies) available for nafamostat and fibrinogen
| Article | Year |
|---|---|
[Bleeding tendency in chronic kidney failure with hemodialysis].
Topics: Benzamidines; Deamino Arginine Vasopressin; Estrogens; Factor VIII; Fibrinogen; Guanidines; Hemorrhagic Disorders; Heparin; Humans; Kidney Failure, Chronic; Renal Dialysis; Thrombocytopenia | 1992 |
Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats.
Topics: Animals; Benzamidines; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guanidines; Hematocrit; Kidney Glomerulus; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains | 1983 |
Discordant liver xenograft transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamidines; Complement System Proteins; Extracorporeal Circulation; Fibrinogen; Graft Rejection; Guanidines; Immunosorbent Techniques; Ketone Bodies; Liver Circulation; Liver Transplantation; Macaca; Protease Inhibitors; Regional Blood Flow; Reperfusion; Swine; Transplantation, Heterologous; Transplantation, Heterotopic | 1994 |
Nafamostat attenuated the impairment of fibrinolysis in animal sepsis model by suppressing the increase of plasminogen activator inhibitor type 1.
Topics: Animals; Benzamidines; Drug Interactions; Fibrinogen; Fibrinolysis; Guanidines; Interleukin-10; Lipopolysaccharides; Liver; Male; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Rats; Rats, Wistar; Sepsis; Serine Proteinase Inhibitors; Tumor Necrosis Factor-alpha | 2006 |
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate.
Topics: Aged; Anticoagulants; Benzamidines; COVID-19; COVID-19 Drug Treatment; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guanidines; Humans; Male; Middle Aged; Retrospective Studies | 2021 |